Sideromimic Modification of Lactivicin Dramatically Increases Potency against Extensively Drug-Resistant Stenotrophomonas maltophilia Clinical Isolates.
Acetamido derivatives of the naturally antibacterial non-β-lactam lactivicin (LTV) have improved activity against their penicillin binding protein targets and reduced hydrolysis by β-lactamases, but penetration into Gram-negative bacteria is still relatively poor. Here we report that modification of...
Main Authors: | Calvopiña, K, Umland, K, Rydzik, A, Hinchliffe, P, Brem, J, Spencer, J, Schofield, C, Avison, M |
---|---|
Format: | Journal article |
Sprog: | English |
Udgivet: |
American Society for Microbiology
2016
|
Lignende værker
-
Structural/mechanistic insights into the efficacy of nonclassical β-lactamase inhibitors against extensively drug resistant Stenotrophomonas maltophilia clinical isolates
af: Calvopiña, K, et al.
Udgivet: (2017) -
Stenotrophomonas maltophilia in Salad
af: Andleeb Qureshi, et al.
Udgivet: (2005-07-01) -
Structural basis for the interaction of lactivicins with serine beta-lactamases.
af: Brown, T, et al.
Udgivet: (2010) -
Effect of Stenotrophomonas maltophilia on Tuberculosis
af: Yue Li, et al.
Udgivet: (2023-08-01) -
Stenotrophomonas maltophilia: An emerging pathogen in sepsis
af: J S Soumya, et al.
Udgivet: (2020-01-01)